innovagenome

innovagenome is a privately held, early-stage personal genomics company founded in 2020 in Brescia, Italy, that states it develops bioinformatics analysis and AI tools for genomic data, led by founder and CEO Nicholas Commisso.

Company typePrivate
Founded2020
HeadquartersBrescia, Italy
Headcount1–10
GTM typeB2B
OfferingSoftware

What innovagenome does

innovagenome is a privately held, early-stage company founded in 2020 and headquartered in Brescia, Italy. The company describes itself as a personal genomics business focused on developing advanced bioinformatics analysis and artificial intelligence tools, targeting the consumer or clinical interpretation of genomic data. It operates with a very small team of 1–10 employees and is led by founder and CEO Nicholas Commisso.

The company's public-facing footprint is minimal: its website (innovagenome.com) currently serves only a verification/loading page rather than substantive product, pricing, or company information. No products, services, APIs, integrations, partnerships, customers, or certifications are disclosed in available sources. There is no record of funding rounds, revenue, or pricing models, and no products-and-services catalog has been published. This combination indicates a pre-commercial or very early commercialization posture, with the company still in build-out phase rather than active market scaling.

Given the absence of disclosed revenue mechanics, customer segments, or go-to-market signals, the business model cannot be reliably characterized. At most, the firm appears to be positioning to monetize bioinformatics and AI-driven genomic analysis tools, but the specific revenue model (direct-to-consumer kits, B2B licensing, clinical partnerships, or research services) is not stated in the source material. The company should be treated as a thin-data, founder-led genomic-AI startup awaiting public evidence of product launch and commercial traction.

innovagenome firmographics

Firmographics

Name: innovagenome
Website: https://innovagenome.com
Company type: Private
Founded year: 2020
Operating status: Operating
Headcount range: 1–10 employees
Short description: innovagenome is a privately held, early-stage personal genomics company founded in 2020 in Brescia, Italy, that states it develops bioinformatics analysis and AI tools for genomic data, led by founder and CEO Nicholas Commisso.
Ownership category
akta.pro rank

innovagenome industry classification

Industry

Product category: Bioinformatics Software
NAICS: Research and Development in Biotechnology (except Nanobiotechnology) (541714), Software Publishers (5132)
akta.pro industry: PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)
SECONDARYHLAAANAA
Genomic Profiling & Sequencing-Based Precision Medicine
Healthcare & Life Sciences/Biotechnology & Biologics/Precision Medicine Solutions

Keywords

Personal genomics services
Bioinformatics analysis tools
AI genomics software
DNA sequencing analytics
Genomic data interpretation

Where innovagenome is headquartered

Location

Headquarters

HQ city: Brescia
HQ country: Italy
HQ region: Europe

Markets served

innovagenome business model

Business model

GTM type: B2B
Offering type: Software
Cost components: Personnel, Technology or R&D, Operations

innovagenome product offering

Product offering

Core offering

innovagenome is a personal genomics company that develops advanced bioinformatics analysis and artificial intelligence tools. The company combines genomics expertise with AI-driven software to support analysis and interpretation of genomic data.

Differentiator

Problem solved

Functional benefit

Products and services

Advanced Bioinformatics Analysis
AI Genomics Tools

Companies that use innovagenome

Customer profile

Ideal customer profiles1 record

innovagenome technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

innovagenome partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights1 record

innovagenome competitors and assessment

Company assessment

Direct peers

Ancestry: Major consumer genomics brand combining DNA testing with family-history and ancestry software. Comparable to innovagenome in end-customer profile (personal genomics consumers) and in using software to interpret genotype data into user-facing insights.
Veritas Genetics: Whole-genome personal-genomics company offering health-risk and carrier screening with proprietary interpretation software. Direct peer in personal genomics with bioinformatics-driven product.
Helix: Sequencing-based personal genomics platform with a software/API layer for health and ancestry applications. Comparable on the 'sequencing + bioinformatics software for personal genomics' axis.
MyHeritage: Consumer-facing DNA testing and family-tree platform with significant European presence. Comparable personal-genomics + software product targeting similar consumer segments.
Nebula Genomics: Personal whole-genome sequencing company with an emphasis on privacy and AI-driven interpretation. Closely matches innovagenome's positioning as a personal-genomics company building advanced bioinformatics and AI tooling.
23andMe: Largest direct-to-consumer personal-genomics company, offering genotyping-based health, ancestry, and trait reports. Directly comparable to innovagenome on the 'personal genomics + interpretation software' axis, though at vastly larger scale.

Broad incumbents

BGI: Global genomics conglomerate with consumer testing (e.g., BGI Health), sequencing platforms, and bioinformatics offerings. Comparable as a broad incumbent in personal genomics and bioinformatics infrastructure.
Illumina: Dominant sequencing-platform vendor that increasingly bundles bioinformatics and AI interpretation. Relevant broad incumbent because its platform choices and software ecosystem shape the addressable market for any independent personal-genomics bioinformatics company.

Emerging players

Sano Genetics: Emerging personal-genomics platform focused on consumer DNA data ownership and research-participant recruitment with software tooling. Comparable as an early-stage, software-led European personal-genomics company.

Regional players

Dante Labs: Italy-based personal genomics and whole-genome sequencing company. Strong regional peer — comparable offering to consumers in the same European market as innovagenome.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks5 records

Key highlights4 records

Customer concentration

innovagenome financial estimates

Financial estimate

Revenue estimate

Valuation estimate

innovagenome leadership team

Management profile

Number of profiles

Profiles1 record

innovagenome funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

innovagenome M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about innovagenome

What does innovagenome do?

Is innovagenome a public or private company?

innovagenome is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was innovagenome founded?

innovagenome was founded in 2020. It employs 1 to 10 people.

Where is innovagenome based?

innovagenome is headquartered in Brescia, Italy, in the Europe region.

Who are innovagenome's main competitors?

Direct peers on record are Ancestry, Veritas Genetics, Helix, MyHeritage, Nebula Genomics and 23andMe. Broad incumbents are BGI and Illumina. Sano Genetics is listed as an emerging player. Dante Labs is listed as a regional player.

Does innovagenome have an API?

No public API is recorded for innovagenome.

What industry is innovagenome in?

innovagenome's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 541714.